NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/26/2026
Back to search
Official data from USPTO
BIOTECON DIAGNOSTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
03/30/2026
Trademark type
Combined
Nice classes
1, 42
Filing date
03/28/2011
Registration date
07/10/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/22/2022
Last transaction
03/30/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Potsdam, DE
Examiner
SAKAI, ADA HAN
Law office
L60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
BIOTECON Diagnostics GmbH
BIOTECON Diagnostics GmbH
Representatives
Bruce S. Londa Norris McLaughlin P.A.
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical compounds used in industry and sciencein particular chemical compounds for conducting gene amplification reactionsalso called polymerase chain reactionsin particular nucleic acidsoligonucleotides and polymerases; reagent kits primarily consisting of chemical compounds for conducting polymerase chain reaction; preparations for purifying foodstuffs or components thereofin particular silica gels; reagent kits containing the aforesaid purifying preparations; monoclonal and polyclonal antibodiesnot for medical purposes; enzymesin particular peroxidasesalkaline phosphatases and galactosidasessubstrates for the aforesaid enzymesnot for medical purposes; reagent kits containing monoclonal and polyclonal antibodiesenzymes and substrates for the aforesaid enzymesnot for medical purposes; diagnostic preparationsexcept for medical and veterinary purposes
Class 42
Foodstuff research and analysis of components and microbial contaminantsin particular by means of gene amplification technology (PCR); conducting of immunological testsin particular enzyme-immunological processes (ELISA)
Publications
History of USPTO decisions and trademark events.
48 publications found
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/15/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/12/2023
INPC
INVALIDATION PROCESSED
09/12/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/22/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
12/22/2022
71AG
REGISTERED-SEC.71 ACCEPTED
12/22/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/22/2022
ES71
TEAS SECTION 71 RECEIVED
06/29/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/10/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
06/11/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/06/2020
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
08/28/2018
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
08/28/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/09/2018
ES75
TEAS SECTION 71 & 15 RECEIVED
06/12/2018
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/10/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/29/2014
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
02/05/2013
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
01/25/2013
GPNX
NOTIFICATION PROCESSED BY IB
12/01/2012
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/17/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/16/2012
FIMP
FINAL DISPOSITION PROCESSED
10/16/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/10/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
07/10/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/24/2012
PUBO
PUBLISHED FOR OPPOSITION
04/24/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/04/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/04/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/04/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/21/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/19/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/17/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/16/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/16/2012
RFNT
REFUSAL PROCESSED BY IB
01/06/2012
MAFR
APPLICATION FILING RECEIPT MAILED
12/20/2011
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/15/2011
RFRR
REFUSAL PROCESSED BY MPU
12/15/2011
DMCC
DATA MODIFICATION COMPLETED
12/15/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/15/2011
CNRT
NON-FINAL ACTION WRITTEN
12/14/2011
ALIE
ASSIGNED TO LIE
12/14/2011
DOCK
ASSIGNED TO EXAMINER
12/14/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/14/2011
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/12/2011
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
12/09/2011
Continuous trademark protection
Get notified about every new filing that threatens BIOTECON DIAGNOSTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.